AGP Picks
View all

Tech News Iraq
Provided by AGP

Tech News Iraq: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News Iraq.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 4, 2026

Science is HERE All Summer at The Tech Interactive
Jun. 4, 2026

Science is HERE All Summer at The Tech Interactive

Indeterminate GlobeNewswire
Unstoppable Branding Agency Announces Upcoming Global Media Features for Dr. Mark Leong, Tina Sue, Karen Romine, and María Esther Panesso Mercado
Jun. 4, 2026

Unstoppable Branding Agency Announces Upcoming Global Media Features for Dr. Mark Leong, Tina Sue, Karen Romine, and María Esther Panesso Mercado

Indeterminate GlobeNewswire
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
Jun. 4, 2026

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option

Indeterminate GlobeNewswire
Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium
Jun. 4, 2026

Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium

Indeterminate GlobeNewswire
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
Jun. 4, 2026

Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors

Indeterminate GlobeNewswire
Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions
Jun. 4, 2026

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions

Indeterminate GlobeNewswire
Satellogic to Participate in June Investor Conferences
Jun. 4, 2026

Satellogic to Participate in June Investor Conferences

Indeterminate GlobeNewswire
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
Jun. 4, 2026

GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE

Indeterminate GlobeNewswire
GILEAD SCIENCES EN LAKEFRONT RONDEN DE OVERNAME VAN OURO MEDICINES AF OM DE PIJPLIJN OP HET GEBIED VAN ONTSTEKINGEN VERDER UIT TE BREIDEN
Jun. 4, 2026

GILEAD SCIENCES EN LAKEFRONT RONDEN DE OVERNAME VAN OURO MEDICINES AF OM DE PIJPLIJN OP HET GEBIED VAN ONTSTEKINGEN VERDER UIT TE BREIDEN

Indeterminate GlobeNewswire
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. 
Jun. 4, 2026

BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. 

Indeterminate GlobeNewswire
ServiceTitan Announces Fiscal First Quarter Financial Results
Jun. 4, 2026

ServiceTitan Announces Fiscal First Quarter Financial Results

Indeterminate GlobeNewswire
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Jun. 4, 2026

Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Indeterminate GlobeNewswire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Jun. 4, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
Jun. 4, 2026

Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress

Indeterminate GlobeNewswire
Climb Global Solutions to Host Investor Day on July 7, 2026
Jun. 4, 2026

Climb Global Solutions to Host Investor Day on July 7, 2026

Indeterminate GlobeNewswire
Merlin Successfully Completes Critical Design Review for C-130J Autonomy Program with USSOCOM
Jun. 4, 2026

Merlin Successfully Completes Critical Design Review for C-130J Autonomy Program with USSOCOM

Indeterminate GlobeNewswire
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jun. 4, 2026

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference
Jun. 4, 2026

Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire
Visure Introduces Engineering Intelligence with the VISURE MCP Server
Jun. 4, 2026

Visure Introduces Engineering Intelligence with the VISURE MCP Server

Indeterminate GlobeNewswire
Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz
Jun. 4, 2026

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Tech News Iraq

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.